Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.2(PAH):c.125A>T (p.Lys42Ile)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA229419

102581 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 295d33fe-390a-46a8-a5cf-dd0c34df16b9

Approved on: 2019-04-07

Published on: 2019-04-07

HGVS expressions

NM_000277.2:c.125A>T

NM_000277.2(PAH):c.125A>T (p.Lys42Ile)

NC_000012.12:g.102912834T>A

CM000674.2:g.102912834T>A

NC_000012.11:g.103306612T>A

CM000674.1:g.103306612T>A

NC_000012.10:g.101830742T>A

NG_008690.1:g.9769A>T

NG_008690.2:g.50577A>T

NM_000277.1:c.125A>T

NM_001354304.1:c.125A>T

NM_000277.3:c.125A>T

ENST00000307000.7:c.110A>T

ENST00000546844.1:c.125A>T

ENST00000548677.2:n.212A>T

ENST00000548928.1:n.47A>T

ENST00000549111.5:n.221A>T

ENST00000550978.6:n.109A>T

ENST00000551337.5:c.125A>T

ENST00000551988.5:n.214A>T

ENST00000553106.5:c.125A>T

ENST00000635500.1:n.93A>T

Likely Pathogenic

PM3 PM2 PS3 PP4

PP3

Evidence Links 4

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.125A>T (p.Lys42Ile) variant in PAH has been reported in 1 individual with classic PKU (BH4 deficiency not assessed/reported). (PP4; PMID: 9380432; 9781015). This variant is absent in population databases (PM2). This variant was detected with p.E280K (Pathogenic in ClinVar) (PM3). This variant has 12% enzyme activity in vitro (PS3; PMID: 21953985). Computational evidence is conflicting. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PS3, PP4, PM2, PM3.

PM3

detected with E280K (VarID580, Pathogenic)

K42I, a novel mutation, and expressed in vivo with E280K (a so-called “severe” allele) confers a 6% oxidation value, implying that K42I is “mild”(Table 4). PubMed:9380432

PM2

Absent from ExAC/gnomAD, 1000 Genomes, ESP

PS3

12% enzyme activity (PMID: 21953985)

We have applied a yeast two-hybrid method, in which protein--protein interactions are measured by four reporter gene constructs, to the analysis of six PKU-associated PAH missense mutations (F39L, K42I, L48S, I65T, A104D, and R157N). PubMed:11461190

p.K42I mutant had 12% total activity as compared to PAH wt. PubMed:21953985

PP4

detected in a patient with variant PKU (<1200 μmol/L) PMID: 9380432, 9781015

K42I occurred in a proband with classical PKU in a PAH genotype (K42I/E280K). PubMed:9781015

K42I was detected in a patient with variant PKU. Patients with variant PKU had pretreatment plasma phenylalanine values lower than those in PKU (<1200 μmol/L), and their dietary tolerance for phenylalanine was higher (>400 mg/d) but not normal. PubMed:9380432

PP3

In silico models do not agree: D in SIFT, MutationTaster; B in PolyPhen2; REVEL=0.933

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.